THYROID HORMONAL CHANGES IN CHRONIC KIDNEY DISEASE: A STUDY OF ENDOTHELIAL FUNCTION AND ALBUMINURIA
Main Article Content
Keywords
Thyroid Hormone, Chronic Kidney Disease, Endothelial Function, Albuminuria
Abstract
Introduction: Endothelial dysfunction is closely linked to both albuminuria and thyroid dysfunction. Albuminuria, the presence of albumin in the urine, is a well-established marker of kidney damage and is associated with an increased risk of cardiovascular disease in CKD patients. Albuminuria is one of the earliest signs of kidney injury and is a strong predictor of adverse outcomes in CKD patients. It is an independent risk factor for both the progression of kidney disease and the development of cardiovascular events.
Material & Methods: An observational, case control study was carried out for 2 years with a Sample Size of 180 with two groups1 (n=90): CKD subjects and group 2 (n=90): Non-CKD subjects. Estimation of Kidney functions, Estimation of Endothelial Function, Estimation of Albumin level was assessed by albumin-to- creatinine ratio (ACR) and Estimation of Thyroid function was done.
Results: The study revealed notable differences in serum creatinine, urea, TSH, and fT3 levels between the two groups, while serum fT4 levels remained unchanged. The biological parameters, including fT3, creatinine, urea, and fT4, exhibit distinct correlations with GFR in different stages of CKD, emphasizing the relationship between kidney function and thyroid hormone levels.
Conclusion: Alterations in thyroid function, particularly hypothyroidism, can exacerbate endothelial injury, contributing to vascular dysfunction and kidney damage. Endothelial dysfunction, in turn, plays a pivotal role in the development of albuminuria, a key marker of kidney injury.
References
2. Biondi, B., & Cooper, D. S. (2008). "The clinical significance of subclinical thyroid dysfunction." Endocrine Reviews, 29(1), 76-131.
3. Galla, J. H. (2004). "Thyroid disease and the kidney." Kidney International, 66(3), 1026-1037.
4. Garofalo, C., et al. (2013). "Thyroid hormones and chronic kidney disease: pathophysiology and clinical implications." European Journal of Endocrinology, 169(3), 1-10.
5. Arosio, E., et al. (2008). "Endothelial dysfunction and inflammation in chronic kidney disease: A review of the literature." Nephrology Dialysis Transplantation, 23(6), 1660-1665.
6. Vaziri, N. D. (2016). "Albuminuria: A marker of endothelial dysfunction in chronic kidney disease." American Journal of Nephrology, 43(5), 320-328.
7. Liao, J. K., & Laufs, U. (2005). "Thyroid hormone and endothelial function." Thyroid, 15(2), 191-195.
8. Izzedine, H., & Boudjedir, K. (2010). "Albuminuria: An early marker of kidney injury in cardiovascular disease." Kidney International, 77(10), 897-902.
9. Tanaka, M., et al. (2013). "Thyroid-stimulating hormone and albuminuria in patients with chronic kidney disease." Journal of Clinical Endocrinology & Metabolism, 98(5), 1986-1993.
10. Du, X., Pan, B., Li, W., Zou, Y., Hua, X., Huang, W., Wan, X., & Cao, C. (2017). Albuminuria is an independent risk factor of T4 elevation in chronic kidney disease. Scientific Reports, 7(1), 1-7
11. Naghavi M., Yen A.A., Lin A.H., Tanaka H., Kleis S. New indices of endothelial function measured by digital thermal monitoring of vascular reactivity: Data from 6084 patients registry. Int. J. Vasc. Med. 2016; 2016:1348028.
12. Witte, K. K., et al. (2007). "The effect of thyroid dysfunction on cardiovascular outcomes in patients with chronic kidney disease." Journal of Clinical Endocrinology & Metabolism, 92(9), 3651-3658.
13. Zoccali, C., et al. (2011). "Albuminuria as a marker of cardiovascular risk in chronic kidney disease." Nephrology Dialysis Transplantation, 26(9), 2790-2797.
14. Liao, J. K., & Laufs, U. (2005). "Thyroid hormone and endothelial function." Thyroid, 15(2), 191-195..
15. Pecoits-Filho, R., et al. (2004). "Endothelial dysfunction in chronic kidney disease." Nephrology Dialysis Transplantation, 19(7), 1713-1717.
16. Ritz, E., & Orth, S. R. (1999). "Endothelial dysfunction and its role in the progression of chronic renal failure." Kidney International, 55(6), 2384-2395.
17. Vasan, R. S., et al. (2001). "Thyroid function and risk for heart failure in the Framingham Heart Study." The Journal of Clinical Endocrinology & Metabolism, 86(6), 2621-2626.
18. Niu, J., et al. (2014). "The association of thyroid dysfunction with kidney function in adults." Thyroid, 24(2), 334-340.
19. Selcuk, S., et al. (2015). "Endothelial dysfunction and inflammatory markers in chronic kidney disease." Nephron Clinical Practice, 130(2), 87-93.
20. Nair, V., et al. (2013). "Endothelial dysfunction in chronic kidney disease." Blood Purification, 36(3), 206-211.
21. Kim, M. J., et al. (2011). "The role of endothelial dysfunction in the pathogenesis of cardiovascular disease in chronic kidney disease." Current Opinion in Nephrology and Hypertension, 20(3), 291-296.
22. Montagnani, M., et al. (2002). "Endothelial dysfunction in chronic kidney disease: Causes and consequences." Nephrology Dialysis Transplantation, 17(2), 247-251.
23. Zoccali, C., et al. (2011). "Albuminuria as a marker of cardiovascular risk in chronic kidney disease." Nephrology Dialysis Transplantation, 26(9), 2790-2797.
24. Witte, K. K., et al. (2007). "The effect of thyroid dysfunction on cardiovascular outcomes in patients with chronic kidney disease." Journal of Clinical Endocrinology & Metabolism, 92(9), 3651-3658.
25. Durr, E., et al. (2013). "The interaction between thyroid function and cardiovascular disease in chronic kidney disease." Nephrology, 18(2), 68-73.
26. Singh, J., et al. (2017). "Thyroid dysfunction and its effect on chronic kidney disease progression." World Journal of Nephrology, 6(3), 156-162.
27. O'Brien, T., et al. (2015). "Endothelial dysfunction as an early predictor of cardiovascular events in chronic kidney disease." Journal of the American College of Cardiology, 65(14), 1484-1492.
28. Gadgil, M., et al. (2017). "The association between thyroid hormones and cardiovascular risk in chronic kidney disease." Kidney & Blood Pressure Research, 42(1), 57-65.
29. Koenig, W., et al. (2004). "Albuminuria and endothelial dysfunction as predictors of cardiovascular mortality in chronic kidney disease." Circulation, 110(3), 392-397.
30. Kremer, A., et al. (2010). "Endothelial dysfunction and chronic kidney disease." European Journal of Clinical Investigation, 40(2), 113-118.
31. Lima, V. M., et al. (2016). "The effect of thyroid hormone on endothelial function and albuminuria in chronic kidney disease." Journal of Endocrinology and Metabolism, 99(5), 2059-2066.
32. Vasile, M., et al. (2015). "Impact of thyroid dysfunction on renal and cardiovascular outcomes in chronic kidney disease." Nephron Clinical Practice, 131(4), 137-145.
33. Glorioso, N., et al. (2014). "Endothelial dysfunction and its relationship with albuminuria in kidney disease." International Journal of Nephrology and Renovascular Disease, 7, 155-162.
34. Wei, W., et al. (2018). "Thyroid hormone levels and their association with endothelial dysfunction in CKD patients." Journal of Clinical Endocrinology & Metabolism, 103(11), 4319-4326.
35. Sarnak, M. J., et al. (2003). "The cardiovascular risk of chronic kidney disease and the importance of thyroid dysfunction." American Journal of Kidney Diseases, 42(3), 494-500.
36. Dardano, A., et al. (2012). "Thyroid function and kidney disease: A complex interplay." Journal of Clinical Endocrinology & Metabolism, 97(6), 1809-1816.
37. Charytan, D. M., et al. (2009). "The role of thyroid dysfunction in the progression of kidney disease." American Journal of Kidney Diseases, 54(3), 419-426.
38. Goyal, A., et al. (2019). "Endothelial dysfunction and thyroid hormones: Mechanistic insights in chronic kidney disease." Kidney International Reports, 4(2), 174-182.